A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder

Clinical trial NCT00273039 · COMPLETED

Trial details

NCT number: NCT00273039
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Social Anxiety Disorder Anxiety Disorders

Start date: 2005-08-01
Primary completion: 2006-09-01
Enrollment: 242

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.